According to GlobalData’s medical device pipeline database, seven Orthotic Splints devices are in various stages of development globally. GlobalData’s report Orthotic Splints provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
All seven devices of this category are in active stage of development. There are four products in the early stages of development, and the remaining three are in the late stages of development.
Orthopedic devices are medical devices that are used to treat or prevent musculoskeletal disorders. Orthopedic splints are devices that provide support, reinforcement, and immobilization to injured joints or other parts of the skeletal tissue until the injury heals. They offer less support than a cast, but are adjustable and easier to use Splints are used to reduce pain and swelling, prevent muscle contractures, and stabilize the injured joint. These devices are utilized for both the upper and lower extremities, as well as the spine.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Orthotic Splints pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Orthotic Splints devices. Overall, most of these Orthotic Splints pipeline devices are being developed by private entities.
Key players involved in the active development of Orthotic Splints include AidPlex, Cambridge University Hospitals NHS Foundation Trust, Indian Institute of Technology Bombay, Manchester University NHS Foundation Trust, MediAsha Technologies, Hospital for Sick Children and University of Antwerp.
For a complete picture of the developmental pipeline for Orthotic Splints devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
